NAVAN, INC. (NAVN)
Navan Strengthens European Train Offering with Swedish Rail Integration
Navan Strengthens European Train Offering with Swedish Rail Integration
KKR to Open New Office in Milan, Strengthening Long-Term Commitment to Italy
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
Investor Presentation - First Quarter of 2026
GPK Investors Have Opportunity to Lead Graphic Packaging Holding Company Securities Fraud Lawsuit with the Schall Law Firm
Clinical trial NCT07218926: enrollment: not set → 450 participants.
Clinical trial NCT06916806: enrollment: not set → 72 participants.
Clinical trial NCT07399132: enrollment: not set → 144 participants.
Clinical trial NCT02231749: enrollment: not set → 1096 participants.
Clinical trial NCT07609914: enrollment: not set → 400 participants.